BioSpace News Archive

4D Molecular Therapeutics, Inc. announced today that management will participate in a fireside chat at an upcoming investor conference in November.

Noema Pharma today announced Robert Lasser, M.D., M.B.A has joined the Company as Chief Medical Officer (CMO).

SciSparc Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, unveiled positive topline results from its investigator-initiated Phase IIa trial at the Sophie & Abraham Stuchynski Israeli Alzheimer’s Medical Center.

Rivus Pharmaceuticals Inc. today announced key clinical and corporate updates.

K36 Therapeutics, Inc. today announced that Benjamin Winograd, MD, PhD, has been appointed Chief Medical Officer to lead the Medical and Clinical teams.

Inhalon Biopharma announced that it has been awarded a $5.7 million contract by the U.S Army Medical Research and Development Command to support a U.S. Army Military Performance Advancement Initiative project to develop new treatments for COVID-19 and other SARS infections.

Reverb Therapeutics Debuts Its Amplifier ™ Platform for Redirecting Endogenous Cytokines.

Athira Pharma, Inc. presented new preclinical data supporting the potential therapeutic benefit of fosgonimeton for the treatment of Alzheimer’s disease and other neurodegenerative diseases at the Society for Neuroscience Annual Meeting 2023, being held in Washington, D.C. from November 11 – 15, 2023.

Shockwave Medical, Inc. announced today that the company will be participating in the Piper Sandler 35th Annual Healthcare Conference, which is being held from Tuesday, November 28 to Thursday, November 30, 2023 in New York, NY.

Yield10 Bioscience, Inc., an agricultural bioscience company, announced that the U.S. Department of Agriculture Animal & Plant Health Inspection Service’s Biotechnology Regulatory Services has determined that Yield10’s stacked herbicide tolerant Camelina sativa may be grown and bred in the United States.